Evidence map›Paper›PMID 39188966›Full record

ArticleParasite epidemiology and control2024

Babesiosis in the immunocompromised population: Results from a multicentric cohort study conducted in Italy.

Anna Barbiero, Simona Gabrielli, Lapo Dani, Michele Spinicci, Filippo Lagi, Gregorio Basile, Francesca Nacci, Antonia Mantella, Seble Tekle Kiros, Angela Pieri and 10 more

Abstract read
In one paragraph

Article in Parasite epidemiology and control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anna BarbieroDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Simona GabrielliDepartment of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Roma, Italy.
Lapo DaniDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Michele SpinicciDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Filippo LagiDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Gregorio BasileDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Francesca NacciSection of Rheumatology, Department of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50125 Florence, Italy.
Antonia MantellaDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Seble Tekle KirosDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Angela PieriDepartment of Infectious Diseases, Provincial Hospital of Bolzano (SABES-ASDAA), Bolzano-Bozen, Italy.
Andrea DelamaInfectious Diseases Unit, Trento Hospital, 38122 Trento, Italy.
Chiara PiubelliDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore-Don Calabria Hospital, 37024 Negrar di Valpolicella, (VR), Italy.
Salvatore ScarsoDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore-Don Calabria Hospital, 37024 Negrar di Valpolicella, (VR), Italy.
Andrea AnghebenDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore-Don Calabria Hospital, 37024 Negrar di Valpolicella, (VR), Italy.
Marcello FeasiDepartment of Infectious Diseases, Galliera Hospital, 16128 Genova, Italy.
Bianca GranozziInfectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Giorgia ComaiNephrology, Dialysis and Renal Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Stefania VaraniUnit of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Lorenzo ZammarchiDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.
Alessandro BartoloniDepartment of Clinical and Experimental Medicine, Università degli Studi di Firenze, 50134 Firenze, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human babesiosis is an emerging zoonotic disease; diffused especially in some regions of the United States, it has been less frequently observed in other continents, including Europe. Serological surveys suggest that babesiosis could be more frequent than expected in European countries, representing an emerging health-issue and a possible harm, especially in immunocompromised populations. Only one case of human babesiosis has been reported in Italy and data about the diffusion of the pathogen in this country are scant. We conducted a multicentric serological survey in 5 centers of North-Eastern Italy, aimed to detect the seroprevalence of

Indexed as

BabesiaHIVImmunosuppressionItalyTick-borne diseasesTicks

Identifiers

PMID39188966
PMCPMC11347065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.